G protein-coupled receptors (GPCRs) respond to agonists to activate downstream enzymatic pathways or to gate ion channel function. Turning off GPCR signaling is known to involve phosphorylation of the GPCR by GPCR kinases (GRKs) to initiate their internalization. The process, however, is relatively slow and cannot account for the faster desensitization responses required to regulate channel gating. Here, we show that GRKs enable rapid desensitization of the G protein-coupled potassium channel (GIRK/Kir3.x) through a mechanism independent of their kinase activity. On GPCR activation, GRKs translocate to the membrane and quench channel activation by competitively binding and titrating G protein bg subunits away from the channel. Of interest, the ability of GRKs to effect this rapid desensitization depends on the receptor type. The findings thus reveal a stimulus-specific, phosphorylationindependent mechanism for rapidly downregulating GPCR activity at the effector level.
INTRODUCTION
G protein-coupled receptors (GPCR) modulate the activity of enzymes and ion channels to fine tune cellular activity (Pierce et al., 2002) . To avoid abnormal cellular activity, GPCR-mediated G protein cycles should be temporally precise. Several mechanisms guarantee the precise length of GPCR activation by controlling the levels of agonist. For example, the level of free neurotransmitters present in the synapse are limited by fast neurotransmitter reuptake at the presynaptic site (Torres et al., 2003) , or degradation at the synaptic cleft (Massoulie et al., 1993) . These processes are specific for specific types of ligands. For regulation at a longer time scale, additional mechanisms control GPCR signaling efficacy. These mechanisms control the robustness of the activation signals by regulating receptor number at the plasma membrane, in a process termed downregulation (Bunemann et al., 1999; Tsao and von Zastrow, 2000) . This mechanism involves a receptor-mediated signaling cascade, where activated receptors are initially phosphorylated by GPCR kinases (GRKs), to initiate intracellular events leading to a clathrin-mediated endocytosis of the GPCRs. This process occurs over a time scale of many minutes to hours.
In the context of GPCR-mediated regulation of ion channel activity, short-term desensitization to an activating signal has been observed. For instance, regulation of GPCR-controlled excitability through the activation of the G protein-coupled potassium channels (GIRK/Kir3.x), displays short-term desensitization characterized by a reduction in channel currents in the presence of the receptor agonist in a time scale of few seconds (Sickmann and Alzheimer, 2003) . This short-term reduction in postsynaptic GIRK channel activity is independent of elements that are known to affect the G protein cycle and PtdIns(4,5)P2 hydrolysis. It is, therefore, of great interest to identify the molecular mechanism that mediates this process.
We set out to identify the mechanism responsible for shortterm desensitization of GIRK channels. We found that for some GPCRs, continued activation of their receptors leads to GIRK current desensitization (GCD). This current desensitization is enhanced in the presence of GRK2 and, surprisingly, does not involve its kinase activity, but rather depends on its ability to bind the Gbg subunits of the G protein. This binding appears to compete for the available pool of the G protein subunits that activate the channel and hence to effectively quench channel activity. These findings assign a new role for the GRK proteins in providing negative feedback control of GPCR function at the effector level.
RESULTS

GRK2 Accelerates Desensitization of GIRK Currents
Induced by A1R and mOR, but Not by mGluR2 and M4R We set out to test the involvement of GRK2 in mediating shortterm desensitization of GIRK channels. GRK2 is involved in the desensitization of GPCRs after exposure to their agonists. For this purpose we expressed GIRK1, GIRK4 (for now on referred as GIRK channels) and adenosine type 1 receptor (A1R) with or without (control) GRK2 in HEK293 cells, and used whole cell patch-clamp recordings to measure various channel current parameters after receptor activation by adenosine ( Figure 1A ). After A1R activation by adenosine (100 mM), GIRK channel currents desensitize (GCD) as evident from the monoexponential decay curve of the current traces with a time constant of 24.9 ± 11.1 s, n = 8 (Figures 1A, upper trace, and 1C) . Interestingly, in cells cotransfected with GRK2, GCD rates were accelerated $10-fold, to 2.6 ± 0.0 s, n = 9 (p < 0.05). To assess whether the enhancement of current desensitization was a general phenomena to all PTX-sensitive GPCRs, we also tested GCD rates induced by m-opioid receptor (mOR). Similar to the effect of GRK2 on A1R-mediated GCD, mOR activation (methionine enkephalin, ME, 100 nM) accelerated GCD in the presence of GRK2 compared to control cells, with a time constant of 38.9 ± 5.9 s, n = 10 and 64.4 ± 6.18 s, n = 7, respectively (see Figures S1A and S1C available online). In contrast, activation of GIRK channels in the absence or presence of GRK2 by metabotropic glutamate type 2 receptor (mGluR2) (Figures 1B and 1C) or muscarinic acetylcholine type 4 receptor (M4R) activation (Figures S1B and S1C) did not show any acceleration in GCD, with time constants 41.7 ± 8.6 s, n = 9 and 41.7 ± 9.5 s, n = 9, (E) GIRK current traces induced by adenosine in control HL-1 cell (black) and of siRNA#1 silenced cell (gray).
(F) Bar plot depicting GCD in HL-1 cells transfected with two independent siRNAs, NT, and siRNA#1 transfected cells rescued by the expression of silently mutated GRK2GFP (smGRK2GFP).
(G) GRK2 mRNA quantification in HL-1 cells transfected with two independent siRNAs or NT control. See also Figure S1 .
respectively for mGluR2, and 37.7 ± 10.7 s, n = 7 and 33.4 ± 11.7 s, n = 6, respectively, for M4R. Like in the case shown above for GRK2, GRK3, but not GRK6, also accelerated GCD in a similar receptor-specific manner (data not shown). Because GRK2 is endogenously expressed in HEK293 cells (Violin et al., 2006) , we were interested to know whether there is a contribution of the endogenous protein to current desensitization in cells not transfected with GRK2. To address this question we silenced endogenous GRK2 levels using shRNA specific for the human GRK2 (shGRK2). GRK2 expression levels were reduced by 58%, as determined using western blot ( Figure 1D ). A1R-induced GIRK currents were significantly slower in GRK2-silenced cells (42.9 ± 6.8 s, n = 12) in comparison with cells cotransfected with nontarget (NT) shRNA (26.0 ± 4.5 s, n = 12) ( Figure 1C ), confirming that endogenous levels of GRK2 are sufficient to enhance GCD rate after A1R simulation. The above results suggest that GRK2 has a role in modulating current desensitization rates of GIRK currents in a receptor-selective manner.
To study whether GRK is also involved in GCD in cells that natively express GIRK, A1R and the kinase, we measured GIRK currents in HL-1 cells. HL-1 is a mouse cardiac muscle cell-line that maintains the characteristics of adult cardiac myocytes, including contraction (Claycomb et al., 1998) . These cells express both GIRK channels and the necessary components for their activation (Nobles et al., 2010) . GIRK currents of HL-1 cells, where GRK2 was silenced using two independent siRNAs, (siGRK2#1 and siGRK2#2) displayed significantly smaller desensitizations compared to cells transfected with NT ( Figures  1E and 1F ). After continuous application of adenosine, the induced currents were reduced to 79.2 ± 11.0% (n = 6), 86.3 ± 7.3% (n = 5) and 24.7 ± 7.4% (n = 6) at 2 min, for both silenced and NT cells, respectively. Expression of silently mutated GRK2-GFP (smGRK2-GFP) in cells silenced with siGRK2#1 rescued the reduction in current desensitization (31.5 ± 12.5%, n = 4) to levels comparable to NT cells ( Figure 1F) . Similarly, GRK2 mRNA levels were reduced in cells transfected with either siGRK2#1 or siGRK2#2 compared to NT control cells with 54.0 ± 2.4% and 57.1 ± 0.6%, respectively ( Figure 1G ). Qualitatively similar results were obtained using primary mouse hippocampal neurons ( Figure S1 ). These experiments suggest that, qualitatively, the effect of GRK in HEK cells is relevant at physiological expression levels, and is not due to overexpression of GRK, the receptors or the channels.
A1R Activation Recruits GRK2-GFP to the Membrane Simultaneously with GIRK Current Desensitization, but Not mGluR2 GRK2 is mainly cytosolic and translocates to the membrane to phosphorylate active receptors (Pitcher et al., 1998) . We wanted to detect these translocations and to test whether there is a correlation between the acceleration of GIRK desensitization rates and GRK translocations. For this purpose, we C-terminally tagged GRK2 with EGFP (GRK2-GFP) and used total internal reflection fluorescence (TIRF) microscopy to detect exclusively the membrane-associated fluorescence (Riven et al., 2003) . Cells transfected with GRK2-GFP and A1R showed a significant GRK2-GFP basal membrane associated fluorescence (Figure 2A) , as previously reported (Garcia-Higuera et al., 1994) . On A1R activation ( Figures 2B and 2C ) the membrane-associated fluorescent signal increased by 22.2 ± 6.2% with a t of 1.5 ± 0.4 s ( Figures 2D and 2F ). mOR also increased membrane associated fluorescence on activation by 10.8 ± 2.8% with a t of 23.4 ± 3.9 s (n = 11), temporally correlated with GCD for this receptor ( Figure S1D ). Similar to the inability of mGluR2 to accelerate GCD, membrane associated fluorescence also did not significantly increase after mGluR2 activation ( Figure 2D) . Similarly, M4R activation by carbachol did not induce GRK2 translocation to the membrane (data not shown). The translocations of GRK2-GFP to the membrane were reversible, as membrane fluorescence returned to its basal level after washing out the agonist ( Figure S2 ). These results may indicate a strong correlation between GRK2 translocation to the plasma membrane and the acceleration in GCD rates. To further strengthen this idea, we recorded A1R induced GIRK currents and measured GRK-GFP translocation simultaneously, using whole cell recording of the patch clamp technique, and quantitative fluorescence under TIRF, respectively ( Figure 2E ). In cells measured this way, GIRK desensitization and GRK2 recruitments to the membrane occurred simultaneously, with change of currents and membrane-associated fluorescence displaying t of 2.4 ± 0.5 s and 4.6 ± 0.9 s, n = 5, respectively. Additional independent observations of GCD rates and membrane-associated fluorescence increase of GRK2-GFP were also temporally correlated with t of 1.3 ± 0.3 s, n = 20 and 1.5 ± 0.4 s, n = 11, respectively ( Figure 2F ).
GPCR Phosphorylation and Receptor Downregulation
Are Not Required for GRK2-Mediated GIRK Current Desensitization In the traditional view, after translocation to the membrane, GRKs are responsible for the phosphorylation of activated GPCRs. This event initiates the process of receptor downregulation by clathrin-mediated endocytosis (Tsao and von Zastrow, 2000) . To examine the relationship between this process and the apparent GRK2-mediated acceleration in GCD as shown above, we tested the ability of GRK2/K220R (dnGRK2), a dominant negative mutant that lacks kinase catalytic activity (Kong et al., 1994) , in accelerating GCD rates ( Figure 3A ). The GCD rates of cell cotransfected with GIRK, A1R, and dnGRK2 (5.5 ± 1.1 s, n = 9) were not different from cells expressing GRK2, the receptor and channel components, with t of 2.6 ± 0.0 s (n = 9), and significantly faster than in cells that were not cotransfected with the kinase (24.9 ± 11.1 s; n = 8). These results suggest that the enhancement of GCD rates is not mediated via the kinase activity of GRK2.
Another possible mechanism for enhancing GCD might be a change in receptor number, independent of GRK2-mediated phosphorylation, or channel number, at the plasma membrane. To test for these two possibilities, we C-terminally tagged the A1R with GFP (A1R-GFP) or C-terminally tagged GIRK4 with GFP (GIRK4-GFP) and measured plasma membrane-associated fluorescence under TIRF. A1R-GFP and GIRK4-GFP plasma membrane levels remained constant in the first minute after agonist application both in control cells and in cells cotransfected with GRK2, with DF/F of 96.3 ± 1.0%; n = 6 and 97.7 ± 0.3%; n = 12, for A1R-GFP and 96.4 ± 0.6%; n = 5 and 106.5 ± 1.4%; n = 9, for GIRK4-GFP, respectively ( Figure 3B ). These results suggest that GRK2-mediated acceleration of the GCD is neither due to a loss of receptors nor due to a loss of GIRK channels from the plasma membrane.
Pertussis Toxin-Insensitive Pathways Are Sufficient to Induce GRK2 Translocations and Acceleration of GIRK Current Desensitization The sensitivity of A1R and mOR to GRK2-mediated desensitization was distinct in comparison to mGluR2 and M4R, GPCRs that display pure Gi/o activation. However, whereas A1R and mOR primarily activate the Gi/o pathway, they may have also a secondary transduction mechanism through different G protein subsets (Cordeaux et al., 2004) . We therefore tested whether other minor secondary G protein activation mechanisms might explain the selectivity of only a subset of receptors to induce GRK2-mediated GCD. To inactivate the Ga i/o pathway, we coexpressed the catalytic subunit of pertussis toxin, PTX-S1, that been shown to effectively abolish GPCR-mediated GIRK activation (Sadja and Reuveny, 2009 ). In cells cotransfected with PTX-S1, A1R, and GIRK channels, A1R activation did not induce GIRK currents, in agreement with Ga i/o sensitivity to PTX ( Figure 3C , middle). In contrast, when cells cotransfected with both GRK2 and PTX-S1 were activated, the basal activity of the GIRK channels, assessed by barium sensitivity of the inward K + currents at À80 mV, was rapidly reduced, in agreement with the observation that a major part of GIRK basal activity is Gbg-dependent (Rishal et al., 2005) . Along the same line, GRK2 translocation to the plasma membrane remained intact, demonstrating that GRK2 membrane recruitment is not dependent on the Ga i/o pathway ( Figures 3D and 3E ). DF/F values without or with PTX were 7.8 ± 0.6%, n = 13 and 8.0 ± 1.0%, n = 7, respectively. As shown above, PTX-insensitive pathways were sufficient to induce GRK2 translocations. The involvement of other G protein signaling pathways, Ga q and Ga s , were also tested and were found not to be involved in GRK2 action on GCD (Figures S3).
The Effects of Mutations in GRK2 that Impair Its Interaction with Various Auxiliary Molecules
GRK2 is known to form a quaternary complex with Ga q and Gbg (Tesmer et al., 2005) . We set out to test whether impairing its ability to interact with these auxiliary proteins may affect the ability of GRK2 to accelerate GCD rates. GRK2 mutations that disrupt GRK2-Ga q interaction, GRK2/R106A;D110A (Day et al., 2004; Sterne-Marr et al., 2003) were tested. These mutations are located in the RGS homology domain that is known to bind Ga q but not Ga i/o (Carman et al., 1999) . GRK2/R106A;D110A also accelerated GCD, similar to wt GRK2 ( Figure S4A ), with t of 1.3 ± 0.4 s, n = 6 and 1.3 ± 0.3 s, n = 20, respectively. GRK2D97-140, a GRK2 mutant that lacks the two helices that are involved in GRK2-Ga q interaction, was also able enhance GCD with t of 3.2 ± 0.8 s; n = 8. These results indicate that GRK2 interaction with Ga q is not required for GRK2 action on GIRK currents. The interactions between GRK2 and Gbg or phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ) have also been thoroughly studied in vitro, with different point mutations in GRK2 PH-domain (Carman et al., 2000; Sterne-Marr et al., 2003; Touhara et al., 1995) . Because both Gbg and PtdIns(4,5)P 2 are key players in the activation of GIRK channels (Huang et al., 1998; Logothetis et al., 1987; Reuveny et al., 1994; Sui et al., 1998) , the GRK2-mediated enhancement of GCD might involve interference of the interactions with these two molecules. We thus compared GCD rates of control and GRK2 transfected cells, and compared them with cells coexpressing the various GRK2 mutants ( Figure 4A ): GRK2/R587Q (Carman et al., 2000) and GRK2/K663E;K665E;K667E , that disrupt the interactions of the kinase with Gbg, and GRK2/ K567E;R578E mutant that disrupts GRK2-PtdIns(4,5)P2 interactions. Disrupting GRK2 interactions with Gbg abolished the GRK2-mediated enhancement of GCD with t of 15.6 ± 1.9 s, n = 32 and 12.6 ± 1.8 s, n = 15 for the GRK2/R587Q and GRK2/K663E;K665E;K667E, respectively ( Figure 4B ). These rates are comparable with cells that do not coexpress GRK2, (t of 19.3 ± 2.1 s, n = 37). Furthermore, mutations that interrupt GRK2 interactions with PtdIns(4,5)P2, GRK2/K567E;R578E partially reduced the enhancement of GCD with t of 5.8 ± 0.6 s, n = 13. When the ability of membrane translocation after receptor activation was tested for both PtdIns(4,5)P2 and Gbg interaction mutants, using GRK2/K567E;R578E-GFP, GRK2/ K663E;K665E;K667E-GFP or GRK2/R587Q-GFP, respectively, translocations to the membrane could be seen, but were reduced in comparison to the wt GRK2 ( Figure S4B ). On the contrary, a triple mutant GRK2/K567E;R578E;R587Q-GFP, in which mutations that disrupt both Gbg and PtdIns(4,5)P2 binding were introduced, no translocations were observed ( Figure S4B ). These results are in agreement with the observations of coordinated interactions of GRK2 with Gbg and PtdIns(4,5)P2 in mediating GRK2 membrane recruitment (Pitcher et al., 1995) .
To address whether the inability of GRK2/R587Q to accelerate GCD is due to its reduced membrane translocation, we tethered wild-type GRK2-GFP and GRK2/R587Q-GFP to the membrane by fusing them with Src-myristoylation signal (myrGRK2-GFP and myrGRK2/R587Q-GFP, respectively) ( Figure 4C ). GCD rates were 1.3 ± 0.5 s (n = 8) and 23.9 ± 5.4 s (n = 5), for myrGRK2-GFP and myrGRK2/R587Q-GFP, respectively (p < 0.05). Moreover, five cells expressing myrGRK2/R587Q-GFP did not display GCD at all. This supports the idea that failure of myrGRK2/ R587Q to accelerate GCD is due to its inability to chelate Gbg, and not due to its impaired membrane targeting.
GRK2 Does Not Cause Desensitization of Constituently Active GIRK Mutants
Because Gbg-GRK2 interactions seem to play an important role in mediating the enhancement of GCD, one possible scenario is that GRK2 is competing with the GIRK channel for Gbg on A1R-activated release. To test this possibility, we examined the effect of GRK on constituently active, Gbg independent GIRK mutant channels (Sadja et al., 2001 ), GIRK1/S170P;GIRK4/S176P (Figure 5A ). To avoid saturation and to ensure high quality voltage clamp, we recorded currents in 5.6 mM external K + solution. Whole cell recordings of GIRK1/S170P;GIRK4/S176P show high basal activity regardless of receptor activation ( Figure S5 ) (Sadja et al., 2001) , with only a minor current induction on adenosine application. In contrast to wt GIRK recordings, GRK2 failed to accelerate the GCD rates of the mutant channels ( Figure 5B ). Currents flowing through GIRK1/S170P;GIRK4/S176P channel mutants without or with GRK2 cotransfection showed current levels of 95 ± 2%, n = 8 and 81 ± 4%, n = 10 (at 5 s of agonist application), respectively. This is in contrast to the significant GCD observed for the wild-type channel that had a reduction of the residual current from 94 ± 14%, n = 7 to only 21 ± 4%, n = 10 with GRK2 cotransfection at the same time point ( Figure 5B ). These findings further point toward the possibility that GRK2-mediated GCD involves the competition between the channel and GRK2 for Gbg subunit. In light of the results described above, we were interested to test whether PtdIns(4,5)P 2 depletion from the channel may also account for GRK2-mediated GCD. Therefore, we took an advantage of the previously described GIRK mutants that display enhanced PtdIns(4,5)P 2 affinity, GIRK1/M223L;GIRK4/ I229L (Koike-Tani et al., 2005; Zhang et al., 1999) ( Figure 5C ). Increasing GIRK channel affinity to PtdIns(4,5)P 2 did not inhibit the action of GRK2 on GCD rates, where GIRK1/M223L; GIRK4/I229L without or with GRK2 showed (at 5 s during agonist application) residual currents of 75 ± 4%, n = 13 and 31 ± 7%, n = 16, respectively. Wild-type GIRK without or with GRK2 showed residual currents of 88 ± 5%, n = 7 and 14 ± 4%, n = 10, respectively ( Figure 5D ). These results demonstrate that GRK2-mediated acceleration of GCD does not occur by PtdIns (4,5)P 2 depletion from the channel.
A1R Activation Increases the Fraction of GRK2-Bound Gbg Population
As shown above, mutations that impair GRK2-Gbg interaction abolish the ability of GRK2 to accelerate GCD. To obtain further evidence that indeed GRK2 binds Gbg in the context of the plasma membrane, we recorded dynamic FRET using fluorescence lifetime approach (FRET-FLIM), under TIRF microscopy. In this method donor fluorescence lifetime is recorded continuously and shortening in donor lifetime is indicative of FRET. For this purpose we used YFP and mCherry as donor and acceptor, respectively. This pair has the advantage of a significant overlap between donor emission and acceptor absorption, yet leaving an acceptor-free donor fluorescence bandwidth for detection, resulting in high FRET efficiencies (Goedhart et al., 2007) (Figure S6A ). YFP has a nearly monoexponential lifetime decay ( Figures S6A and S6B) (Kremers et al., 2006) , making it suitable for use as a donor for FLIM measurements. Although cytosolic (A) Typical traces of GIRK1/S170P;GIRK4/S176P channel mutants, without (upper trace) or in the presence of GRK2 (lower trace).
(B) A bar plot summarizing the residual current (in % of total current) after agonist application without (dark gray) and in the presence of GRK2 (light gray).
(C) Typical current traces of GIRK1/M223L;GIRK4/ I229L channel mutants, without (upper trace) or in the presence of GRK2 (lower trace).
(D) A bar plot summarizing the residual current (in % of induced current) after agonist application from cell without (dark gray) and with GRK2 (light gray). In both case, desensitization was measure 5 s after agonist application. See also Figure S5 .
YFP showed a t of 2.6 ± 0.0 ns, n = 10, in a fused dimer of YFP and mCherry a subpopulation (92.9 ± 0.5%) of the donor molecules displayed a much shorter lifetime (0.6 ± 0.0 ns) corresponding to a FRET efficiency of 76.7 ± 0.2%, n = 10 ( Figure S6A ). We set out to measure the changes in FRET between N-terminally fused Gb1 with YFP (YFP-Gb1) (Riven et al., 2006) and C-terminally fused GRK2 with mCherry (GRK2-Cherry) ( Figure 6A ). On A1R activation YFP-Gb1 fluorescence decreased in the presence of GRK2-Cherry, in agreement with YFP fluorescence quenching by mCherry due to FRET ( Figure 6B ). Fitting the fluorescence lifetime decays of the donor over time revealed that, at rest, two donor subpopulations exist ( Figure 6C ). One subpopulation (22.6 ± 0.9%, n = 8) contains YFP-Gb1 proteins that interact with GRK2-Cherry and hence result in shorter fluorescent lifetimes of 0.6 ± 0.1 ns, n = 8. The remaining fraction consists of free YFP-Gb1 proteins that display the characteristic monoexponential lifetime of YFP-Gb1 monomers (t-3.04 ns; see Figure S6B) . After A1R activation, the relative fraction of YFP-Gb1 subunits that interact with GRK2-Cherry increases, seen as an increase in the relative fraction of the shorter lifetime constants (to 29.4 ± 1.6%, n = 8, p < 0.05) and as a decrease in the fraction displaying long lifetime of the YFP (Figure 6C, D) . The time course of the shift in relative fraction of short and long lifetimes (4.2 ± 0.7 s) resembles GCD rates and GRK2 translocations. Similar correlation was seen when mOR was used, the rates of YFP-Gb1 association with GRK2-Cherry was similar to the GCD and to the GRK2-GFP translocation rates, with t average for binding increase of 69.5 ± 15.3 s (n = 6) ( Figure S6C ). These findings support the above observations that GRK2 action on GCD is mediated through the binding of Gbg to GRK2.
DISCUSSION
Desensitization is an important cellular mechanism that allows cells to adapt to long-term external stimuli. In the case of GPCR signaling pathways, desensitization is mediated by a decrease in the cellular response to a continuous GPCR stimulation by agonists, resulting in a decrease in receptor number at the plasma membrane. This process, that takes minutes to hours, is mediated by phosphorylation of the receptor by GRK, leading to clathrin-mediated endocytosis, in a process termed downregulation (Bunemann et al., 1999; Tsao and von Zastrow, 2000) . In addition to this well characterized process, other mechanisms are necessary for a more rapid control of GPCRmediated signaling, specifically when the signal is intended to control changes in electrical responsiveness of cells. In this study we have described a mechanism that is responsible for the termination of GPCR-mediated activation of GIRK channels, which occurs within seconds.
In locus ceruleus neurons, Blanchet and Luscher (2002) showed that prolonged activation of the mOR leads to inhibition of GIRK function. It was shown that whereas mOR-mediated presynaptic inhibition remained constant over time, postsynaptic inhibition, mediated by GIRK activation, showed strong desensitization of the response, indicating control over the GIRK currents downstream of the receptors. This decrease in GIRK currents could be overcome by additional activation of G protein pathways. As a possible model for their results, it was suggested that the receptor might activate Gbg scavengers such as GRK2 and GRK3, to induce competitive inhibition on GIRK activation. In a separate study using the same neurons, it was shown that GCD was dependent on two molecular pathways, the b-arrestin/GRK2 and the ERK1/2 pathways (Dang et al., 2009 ). These findings suggested that GCD might involve modifications of the G protein pathway that serves to translate receptor activation to GIRK gating. In contrast, GCD by muscarinic receptor stimulation has been attributed to a mechanism solely involved the GPCR phosphorylationdependent and independent mechanisms by GRK2, and not the G protein subunits (Shui et al., 1998) . Here, using electrophysiological and fluorescence resonance energy transfer techniques, we unequivocally demonstrate that GRK2 is the component of the G protein pathway that mediates this short-term current decrease in the presence of the receptor agonist. The molecular mechanism of this action will be discussed below.
Based on our results, we suggest the following mechanism for GRK2-mediated GCD (Figure 7 ): at rest, trimeric G-proteins are bound to the nonactivated Gi/o-coupled GPCR and the channel (Riven et al., 2006) . After receptor activation by an agonist, the Gbg subunits dissociate from the Ga subunit to interact with the Gbg-binding domains on the channel, and promote channel gating (opening). At the same time, GRK2 is recruited, either within the two-dimensional space of the membrane (within 100 nm of the membrane space), or through the classical cytosolic-to-plasma membrane translocation (Pitcher et al., 1998) . The former possibility may be aided by PtdIns(4,5)P2 or by other membrane associated proteins, including the GIRK1 channel subunit (Dhami et al., 2004; Li et al., 2003; Palczewski, 1997; Rishal et al., 2005) . This recruitment of GRK2, which is in our case a receptor-specific event, promotes the binding of the Gbg subunit to GRK2 or GRK3, but not GRK6 that lacks Gbg binding capability, and thus reduces the availability of the Gbg subunits to the channel. To have this chelation capacity, GRK2 has to have a higher or comparable affinity for Gbg than does the channel. Indeed, from binding studies it has been shown that Gbg subunits bind recombinant GIRK1 or GIRK4 subunits with dissociation constants of $125 nM and $50 nM, respectively (Krapivinsky et al., 1995) , whereas Gbg affinity for GRK2 is $20 nM (Pitcher et al., 1992; Wu et al., 1998) . Further evidence to support the idea that differential affinity to Gbg may mediate this action comes from experiments where GIRK4 was overexpressed in atrial myocytes (Bender et al., 2001). In these experiments, GCD rates were greatly reduced, in comparison to the GCD of GIRK1/4 heterotetramer, supporting the idea that high affinity binding of Gbg may determine the extent of channel current desensitization. Removal of Gbg from the channel by GRK to affect channel function may not require the removal of all four Gbg subunits, due to the steep dependence of channel function on Gbg binding (Sadja et al., 2002) . Removing only one Gbg dimer reduces the efficacy of gating by $70%. Finally, by using other means to chelate Gbg on the membrane, such as coexpression of phosducin, similar effects on GCD can be achieved (Riven et al., 2006) . In conclusion, the evidence provided above strongly points toward the possibility that the acceleration of GCD by GRK2 is due to competition for Gbg dimers with the channel. How may GRK2-mediated GCD be interpreted in light of previous suggested mechanisms? Few other mechanisms have been proposed in the past to explain GCD. It has been proposed that GIRK desensitization in cardiac cells might result from simultaneous activation of M2R and M3R of the Gi/o and the Gq pathways by acetylcholine, respectively (Keselman et al., 2007; Kobrinsky et al., 2000; Meyer et al., 2001) . Whereas the former leads to GIRK opening, the latter leads to GCD by PLC-mediated PtdIns(4,5)P2 depletion. Evidently, GCD occurs also in simpler cases, where cross-talk between different GPCRs pathways are probably not involved, and can be independent of PtdIns(4,5)P2 depletion as showed by the use of PLC inhibitors or activators Sickmann and Alzheimer, 2003) . This was also true for our observations using NCDC, a PLC inhibitor that does not block GIRK channel function (Sickmann et al., 2008) . Furthermore, as shown above, mutations that affect the affinity of the channel to PtdIns(4,5)P2 (Koike-Tani et al., 2005; Zhang et al., 1999) , are not affecting GRK2-mediated channel desensitization. We thus suggest that changes in PtdIns (4,5)P2 may only be an additional form of a much slower regulation of channel function, mediated by the enzymatic activity of PLC (Kobrinsky et al., 2000) .
Our observations show that among four different receptors described in this study, GCD was tightly regulated by GRK2 in currents induced by A1R and mOR, showing a very robust acceleration of GCD. On the contrary two other receptors, namely mGluR2 and M4R were not able to induce GCD in the presence of GRK2. How might this receptor selectivity be addressed? It is interesting to note that receptors that were not able to support GRK2-mediated GCD, were also not able to recruit GRK2 to the plasma membrane, even though they all release Gbg on activation to gate GIRK channels. This may suggest that different receptors have differential mechanisms to recruit GRK2 to the plasma membrane. The process of membrane recruitment of GRK proteins has been ascribed to a Gbg subunit-dependent mechanism (Pitcher et al., 1998; Pitcher et al., 1992) . It is therefore not clear how only a subset of receptors have the ability to recruit the kinase, where others, that also release Gbg to activate the GIRK channels, do not. We have tried to address this issue and found that neither PLC inhibition by NCDC, treatment with pertussis toxin, or using dominant negative Ga s mutant (Berlot, 2002) affected the ability of the receptor to recruit GRK2 to the membrane (see Figure S3 ). This may suggest of other still unknown mechanisms that mediate this process by selective type of GPCRs, probably by a specific direct interaction of the intracellular loops of the receptor with GRK2.
How might the immediate desensitization be achieved? In addition to cytosolic GRK that is recruited to the membrane on receptor activation, a basal membranous subpopulation of GRK2 is observed by us and by others (Aragay et al., 1998; Garcia-Higuera et al., 1994; Murga et al., 1998) . This subpopulation can enable the immediate negative feedback of GIRK activation. We cannot rule out also the possibility that GRK is precoupled to GIRK (Rishal et al., 2005) and undergoes an orientation/conformation change on activation, enabling its immediate competition with the channels for Gbg subunits. There are many studies suggesting the existence of signaling complex between GIRK and Gbg (Clancy et al., 2005; Doupnik, 2008; Nikolov and Ivanova-Nikolova, 2004; Riven et al., 2006) . The GIRK-Gbg precoupling, before GPCR activation, might enable the specificity of GPCR signaling cascade in an environment that may be populated by receptors of different types. Gbg precoupled to GIRK undergo local rearrangement on GPCR activation to immediately transduce GIRK gating independent of diffusion rates (Riven et al., 2006) . So if indeed the effector (GIRK) is a module precoupled to its ''switch-on,'' could it be that it is also precoupled to its ''switch-off''? There is evidence that GRK2 and GIRK channel encompass a common signaling complex (Nikolov and Ivanova-Nikolova, 2004 ). On receptor stimulation by GPCR, the G protein trimer undergoes activation characterized by the exchange of GDP for GTP on the Ga subunit. This in turn leads to the dissociation of the Gbg subunits to freely bind and activate the GIRK channel. Concomitantly, the GPCR induces the recruitment of GRK2 to the plasma membrane making it available to bind Gbg subunits of the G protein. Due to the relative higher affinity of GRK2 for Gbg and to the larger mass action, GRK2 is now able to effectively compete for the available pool of Gbg with the GIRK channel, leading to a gradual removal of the Gbg subunits and to a channel closure (desensitization), still in the presence of the receptor agonist. Channel activation precedes the action of GRK2 mainly due to the preexisting trimeric G proteins in the vicinity of the channels (Riven et al., 2006) .
Our results add a unique aspect to emerging evidence for phosphorylation-independent activity of the GRK family, from the regulation of receptor numbers or uncoupling of the GPCR from the G protein at the plasma membrane, to regulation of intracellular enzymes (for reviews see Ferguson [2007] and Reiter and Lefkowitz [2006] ). In all of these cases, there is no indication of a direct involvement of the Gbg subunits of the G protein in GRK action. GPCR/GRK2-dependent action on channel activity, or other effectors, forms a new mechanism for a short-term negative feedback for GPCR function, that selectively regulate effector activity in the continued presence of receptor agonists. This mechanism may not exclusively pertain to GIRK channels, but can be relevant to all membrane associated Gbg regulated effectors (Dupre et al., 2009) . Because drug therapies for many diseases are targeted to the receptor, a better understanding of the pathway that links receptor to effector activation and regulation (in this case the GIRK channel), and finding new means to regulate these steps, might lead to therapies with better resistance to complications such as tolerance and side-effects.
EXPERIMENTAL PROCEDURES
Patch-Clamp Recordings
Membrane currents were recorded under voltage-clamp conditions using whole-cell patch-clamp configuration with an Axopatch 200B (Axon Instruments) patch-clamp amplifier. Patch pipettes were fabricated from borosilicate glass capillaries (2-5 MU). Signals were analog filtered using a 1 kHz low-pass Bessel filter. After patch formation in a low K + bath solution, the bath solution was changed to high K + solution. Adenosine (100 mM), glutamate (100 mM), methionine enkephalin (ME, 100 nM), carbachol (100 mM), and Ba +2 (3 mM) were used to study induced and basal GIRK currents. GIRK currents were measured as inward currents at a holding potential of À80 mV at room temperature. Data acquisition and analysis were done using pCLAMP 9 software (Axon Instruments). To determine GCD kinetics, current traces were fitted to a monoexponential decay function using Chebyshev method. Results are expressed as average ± standard error of the mean (SEM). Significant differences were considered when p < 0.05 using Student's t test.
TIRF Microscopy
Fluorescence was measured using through the objective TIRF microscopy (Riven et al., 2003 ) with a 60 3 1.45 N.A. TIRFM objective (Olympus, Japan) and TIRF condenser (TILL Photonics, Germany). Images were acquired with Ixon+ EMCCD camera (Andor, Ireland) using Imaging Workbench 6 software (Indec, USA). DF/F (%) was calculated from ROI that contained the whole cell membrane area and was background subtracted. Time constant (t) for GRK2 translocations, was calculated by determining the time after agonist application when fluorescence reached 63% of maximum.
Fluorescence Lifetime Measurements
For fluorescence lifetime measurements (FLIM), 470 nm ps diode laser (FWHM < 90 ps) was used, driven by a 40 MHz pulse controller, PDL 800-B. Single photons were collected using PMA-165P photon counter and processed using TimeHarp 200 PC-board. Data was acquired and analyzed using SymPhoTime software (PicoQuant, Germany). Donor fluorescence was collected from single cells under TIRF configuration (Riven et al., 2003) . For all measurements, laser intensities were set such that signal count rate will be <1% of laser pulse rate. IRF was reconstructed from lifetime measurement of YFP-Gb1 under TIRF using laser powers comparable to those used in the experiment. YFP-Gb1 monomer lifetime was monoexponential with t of 3.0 ns ( Figure S6B ). To extract lifetimes and relative intensities, donor fluorescence traces were binned to 1-s segments and IRF reconvoluted trace was fitted to double-exponential fitting model. One t parameter, t d , was constrained to 3.0 ns (YFP-Gb1), and t da as well as the relative size for each exponential term was extracted from fitting result (Lleres et al., 2007; Peter et al., 2005; Wallrabe and Periasamy, 2005; Yasuda et al., 2006) . Maximum likelihood estimation (MLE) method was used for fitting. Fit quality was examined both by c 2 values and by the absence of systematic variations of fit residuals.
Molecular Biology and Cell Culture
Fusions to fluorescent proteins (EGFP, YFP and mCherry) were based on commercially available pCMV-XFP vectors (Clontech). In EGFP A206K point mutation was made to eliminate its week dimerization tendency (Zacharias et al., 2002) . Point mutations and deletion done in GIRK and GRK2 were carried out by polymerase chain reaction (PCR) and verified by sequencing. Nonfused GIRK and PTX-S1 subunits (Sadja and Reuveny, 2009) were all in pcDNA3.1 (Invitrogen). C-terminal fusion of fluorescent proteins to GRK2 did not affect its function. HEK293 cells were transiently transfected using Metafectene (Biontex, Germany) with cDNAs encoding for the channel subunits, the receptor of choice and GRK (wt, GFP-fused or mutant). In GRK2 silencing experiments GRK2 shRNA (0.1 mg) or nontarget control (0.1 mg) was cotransfected with the channel and the receptor. Currents were measured 24-48 hr posttransfection according to Raveh et al. (2008) . The HL-1 cells, a gift from Dr. William C. Claycomb, were maintained using the recommended protocols (Claycomb et al., 1998) . For electrophysiology experiments, cells were transferred to uncoated 24-mm glass coverslips on the day of the recording.
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